Jonas Salk's initial testing of polio vaccine is 60 - 70% effective against PV1 (poliovirus type 1, over 90% effective against PV2 and PV3, and 94% effective against the development of bulbar polio.
Salk was hailed as a "miracle worker", and the day "almost became a national holiday." His sole focus had been to develop a safe and effective vaccine as rapidly as possible, with no interest in...